Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10001
CALL
Allogene Therapeutics
ALLO
$708M
| $264K | ﹤0.01% |
23,200
-5,700
| -20% | -$50.6K |
|
10002
Roundhill Sports Betting & iGaming ETF
BETZ
$50.9M
| $264K | ﹤0.01% |
+18,321
| New | +$307K |
|
10003
CALL
Flywire
FLYW
$2.29B
| $264K | ﹤0.01% |
15,000
+2,700
| +22% | +$62.7K |
|
|
10004
Fortive
FTV
$18.6B
| $264K | ﹤0.01% |
6,437
-8,797,296
| -100% | -$389M |
|
|
ISPO
10005
PUT
DELISTED
Inspirato
ISPO
| $264K | ﹤0.01% |
+2,850
| New | +$329K |
|
10006
PUT
Lakeland Industries
LAKE
$117M
| $264K | ﹤0.01% |
17,200
-42,700
| -71% | -$726K |
|
10007
OneAscent Large Cap Core ETF
OALC
$261M
| $264K | ﹤0.01% |
+13,355
| New | +$283K |
|
|
ONL
10008
PUT
Orion Office REIT
ONL
$164M
| $264K | ﹤0.01% |
24,060
-102,324
| -81% | -$1.32M |
|
10009
CALL
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$606M
| $264K | ﹤0.01% |
+4,300
| New | +$301K |
|
10010
CALL
Sabesp
SBS
$16.2B
| $264K | ﹤0.01% |
170,681
-31,455
| -16% | -$56.7K |
|
10011
CALL
Kartoon Studios
TOON
$37.4M
| $264K | ﹤0.01% |
34,880
-740
| -2% | -$5.66K |
|
10012
PUT
Arcturus Therapeutics
ARCT
$234M
| $263K | ﹤0.01% |
16,700
-13,700
| -45% | -$269K |
|
10013
PUT
iShares MSCI Singapore ETF
EWS
$1.17B
| $263K | ﹤0.01% |
14,900
-10,300
| -41% | -$196K |
|
|
HOLX
10014
DELISTED
Hologic
HOLX
| $263K | ﹤0.01% |
+3,799
| New | +$282K |
|
10015
CALL
Maximus
MMS
$2.89B
| $263K | ﹤0.01% |
4,200
-5,900
| -58% | -$399K |
|
10016
PUT
Sixth Street Specialty
TSLX
$1.78B
| $263K | ﹤0.01% |
+14,200
| New | +$301K |
|
10017
Harbor Long-Term Growers ETF
WINN
$1.2B
| $263K | ﹤0.01% |
+18,592
| New | +$295K |
|
|
PROC
10018
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
| $263K | ﹤0.01% |
+28,187
| New | +$234K |
|
10019
Byline Bancorp
BY
$1.78B
| $262K | ﹤0.01% |
11,015
+3,421
| +45% | +$82.7K |
|
10020
CALL
Kodiak Sciences
KOD
$2.6B
| $262K | ﹤0.01% |
34,300
-138,000
| -80% | -$969K |
|
10021
PUT
Landstar System
LSTR
$6.45B
| $262K | ﹤0.01% |
1,800
-1,900
| -51% | -$283K |
|
10022
PUT
Patria Investments
PAX
$1.86B
| $262K | ﹤0.01% |
19,800
| – | – |
|
10023
PUT
VanEck Steel ETF
SLX
$173M
| $262K | ﹤0.01% |
5,300
+100
| +2% | +$6.07K |
|
10024
CALL
Smith & Nephew
SNN
$12.5B
| $262K | ﹤0.01% |
9,400
-6,800
| -42% | -$212K |
|
10025
PUT
Cars.com
CARS
$663M
| $261K | ﹤0.01% |
27,700
-11,900
| -30% | -$129K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.